KALA BIO(DE:27F)
€3.400.00 (0.00%)
DE:27F
KALA BIO financials statements
€3.40
At close:0.00 (0.00%)
KALA BIO (27F) Ratios
0 Followers
KALA BIO Ratios
DE:27F's free cash flow for Q2 2026 was $-1.53M. For the 2026 fiscal year, DE:27F's free cash flow was increased by $0.00 and operating cash flow was $-1.53M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.81 | 3.11 | 6.33 | 3.35 | 3.32 |
| Quick Ratio | 3.81 | 3.11 | 6.33 | 3.35 | 3.09 |
| Cash Ratio | 3.03 | 3.02 | 6.10 | 2.74 | 2.46 |
| Solvency Ratio | -10.69 | -0.89 | -0.86 | -0.65 | -1.14 |
| Operating Cash Flow Ratio | -12.83 | -1.73 | -3.35 | -3.07 | -2.89 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -2.84 | -83.61 | -15.78 | -152.23 |
| Net Current Asset Value | $ 7.00M | $ 9.65M | $ 4.42M | $ 18.10M | $ 1.74M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.58 | 0.65 | 0.49 | 0.58 |
| Debt-to-Equity Ratio | 0.00 | 2.62 | 4.84 | 2.26 | 4.77 |
| Debt-to-Capital Ratio | 0.00 | 0.72 | 0.83 | 0.69 | 0.83 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.62 | 0.82 | 0.67 | 0.82 |
| Financial Leverage Ratio | 1.36 | 4.50 | 7.46 | 4.58 | 8.30 |
| Debt Service Coverage Ratio | -7.14 | -2.01 | -5.87 | -2.99 | -14.52 |
| Interest Coverage Ratio | -11.95 | -6.99 | -6.73 | -11.20 | -13.06 |
| Debt to Market Cap | 0.00 | 0.02 | 2.03 | 0.74 | 1.01 |
| Interest Debt Per Share | 20.10 | 6.89 | 17.33 | 33.02 | 67.92 |
| Net Debt to EBITDA | 0.32 | 0.58 | 0.40 | 0.75 | 0.09 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 34.22% | 63.55% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | -964.95% | -1194.17% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | -942.86% | -1173.99% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | -2090.34% | -973.60% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | -1151.64% | -1268.73% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | -1151.64% | -1268.73% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | -1151.64% | -1268.73% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 68.90% | 95.24% | 107.78% | 55.09% | 130.31% |
| Return on Assets (ROA) | -284.30% | -69.41% | -75.42% | -51.63% | -102.28% |
| Return on Equity (ROE) | -385.65% | -312.29% | -562.35% | -236.23% | -848.64% |
| Return on Capital Employed (ROCE) | -559.76% | -104.95% | -82.25% | -133.08% | -107.28% |
| Return on Invested Capital (ROIC) | -559.76% | -82.11% | -81.11% | -122.99% | -105.81% |
| Return on Tangible Assets | -284.30% | -69.41% | -75.42% | -51.63% | -102.28% |
| Earnings Yield | -595.53% | -2.01% | -247.88% | -77.26% | -180.75% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.60 | 0.64 |
| Payables Turnover | 0.00 | 0.41 | 0.33 | 1.09 | 1.47 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.47 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 9.36 | 2.80 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.04 | 0.08 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.05 | 0.10 |
| Cash Conversion Cycle | 0.00 | -885.02 | -1107.05 | 274.39 | 1088.89 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 609.30 | 566.82 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 769.64 |
| Days of Payables Outstanding | 0.00 | 885.02 | 1107.05 | 334.92 | 247.58 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 609.30 | 1336.47 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -196.31 | -5.32 | -11.48 | -51.89 | -83.00 |
| Free Cash Flow Per Share | -196.31 | -5.36 | -11.73 | -52.10 | -83.68 |
| Dividend Paid and CapEx Coverage Ratio | -2132.73 | -141.26 | -45.78 | -252.10 | -122.16 |
| Capital Expenditure Coverage Ratio | -2132.73 | -141.26 | -45.78 | -252.10 | -122.16 |
| Operating Cash Flow Coverage Ratio | 0.00 | -0.91 | -0.77 | -1.84 | -1.35 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | -20.27 | -9.63 |
| Free Cash Flow Yield | -706.14% | -1.54% | -167.63% | -136.56% | -138.31% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.17 | -49.71 | -0.40 | -1.29 | -0.55 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 14.91 | 7.02 |
| Price-to-Book (P/B) Ratio | 0.65 | 155.33 | 2.27 | 3.06 | 4.70 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.14 | -64.74 | -0.60 | -0.73 | -0.72 |
| Price-to-Operating Cash Flow Ratio | -0.14 | -65.19 | -0.61 | -0.74 | -0.73 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.83 | 0.01 | 0.02 | -0.06 |
| Enterprise Value Multiple | 0.13 | -58.41 | -0.07 | -0.83 | -0.51 |
| Enterprise Value | -3.03M | 1.90B | 2.45M | 30.47M | 66.95M |
| EV to EBITDA | 0.13 | -58.41 | -0.07 | -0.83 | -0.51 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 7.83 | 5.96 |
| EV to Free Cash Flow | 0.09 | -64.10 | -0.09 | -0.38 | -0.61 |
| EV to Operating Cash Flow | 0.09 | -64.55 | -0.09 | -0.39 | -0.62 |
| Tangible Book Value Per Share | 42.93 | 2.23 | 3.09 | 12.48 | 12.89 |
| Shareholders’ Equity Per Share | 42.93 | 2.23 | 3.09 | 12.48 | 12.89 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 2.56 | 8.62 |
| Net Income Per Share | -165.56 | -6.98 | -17.35 | -29.48 | -109.35 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.14 | 1.18 | 1.16 | 1.19 | 1.06 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 4.54 | 1.02 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 16.71 | 9.35 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 1.80 | 1.43 |
| Income Quality | 1.19 | 0.76 | 0.66 | 1.76 | 0.76 |
Currency in USD
